The Kidney PATIENT Act National Campaign


Effective January 1, 2025, CMS plans to change coverage for oral-only phosphate lowering therapies (PLTs) drugs for patients with kidney failure. This could jeopardize patients’ access to vital medications and raise dialysis treatment costs. Introduced by Reps. Earl L. “Buddy” Carter, Ann McLane Kuster, Carol Miller, and Terri Sewell, the bipartisan Kidney PATIENT Act (H.R. 5074) aims to postpone this change until 2033 or until new intravenous therapies become available. State and National stakeholders from the kidney community and beyond have called on Washington to act quickly and exclude oral-only phosphate lowering therapies (PLTs) from the End Stage Renal Disease Prospective Payment System or ESRD Bundle.

H.R. 5074 | Kidney PATIENT Act


“Protecting Dialysis Patients with Kidney Failure”

Ensuring Access to Life-Saving ESRD Oral-Only Medicines within Medicare

A Special 2-Part Program

Milwaukee, WI | July 19-20, 2024

July 19: 4:00 pm - 6:30 pm CT

July 20: 10:00 am - 12:30 pm CT

St. Paul Church of God in Christ, Milwaukee

2661 N 53rd St, Milwaukee, WI 53210


*Stay tuned for more details*


In Partnership with

HEAL Collaborative and Ardelyx


Help HEAL support the Kidney PATIENT Act (H.R. 5074) Sign the Petition.


Let Your Voice Be Heard!


Past Programs

Thank you to our partners. Your commitment to change provides an abundance of hope.